NRx Pharmaceuticals Presents Evidence ZYESAMI™ (aviptadil) Helps Prevent “Cytokine Storm” in Patients with COVID-19
NRx Pharmaceuticals Presents Evidence ZYESAMI (aviptadil) Helps Prevent “Cytokine Storm” in Patients with COVID-19
Tweet this
Health regulators continue to prioritize therapies for COVID-19 which help block the impact of IL-6 cytokines in patients with…
